GlassScriptPhysician profile
Larry K Beck
NPI 1851356042
$1,120.47
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $351 · 2023: $14.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $167.01 | 2019-2020 | |
| Incyte Corporation | $140.00 | 2019-2020 | |
| Seagen INC. | $112.82 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $81.62 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $66.94 | 2019-2020 | |
| Pfizer INC. | $61.09 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $51.10 | 2019 | |
| Genzyme Corporation | $49.31 | 2019-2020 | |
| Celgene Corporation | $49.20 | 2019 | |
| Astellas Pharma US INC | $44.68 | 2019-2020 | |
| Amgen INC. | $39.13 | 2019 | |
| Janssen Biotech, INC. | $36.52 | 2019 | |
| Tesaro, INC. | $31.81 | 2019 | |
| Rigel Pharmaceuticals, INC. | $27.75 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $21.31 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $20.66 | 2019 | |
| Daiichi Sankyo INC. | $19.88 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.77 | 2019 | |
| Lilly USA, LLC | $15.58 | 2019 | |
| Abbvie INC. | $14.85 | 2023 | Venclexta |
| Exelixis INC. | $14.84 | 2019 | |
| Puma Biotechnology, INC. | $13.60 | 2019 | |
| Mylan Institutional INC. | $13.00 | 2020 | |
| Genentech USA, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.